The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor

Genes and Development

Volumn 12, Issue 19, 1998, Pages 2992-2996

  Li, Xiao Yong ^a   Green, Michael R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Elongation factor; HIV 1; Tat; Tat SF1; Transcription

Indexed keywords

ELONGATION FACTOR; TRANSACTIVATOR PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; DNA BINDING; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032190621     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.19.2992     Document Type: Article

References (35)

1. Aso, T., W.S. Lane, J.W. Conaway, and R.C. Conaway. 1995. Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II. Science 269: 1439-1443.
2. Bentley, D.L. 1995. Regulation of transcriptional elongation by RNA polymerase II. Curr. Opin. Genet. Dev. 5: 210-216.
3. Bertolotti, A., Y. Lutz, D.J. Heard, P. Chamhon, and L. Tora. 1996. hTAFII68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15: 5022-5031.
4. Cullen, B.R. 1993. Does HIV-1 Tat induce a change in viral initation rights? Cell 73: 417-420.
5. Cujec, T., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. Morgan, and B. Peterlin. 1997. The HIV trans-activator Tat hinds to the CDK-activating kinase (CAK) and activates the phosphorylation of the C-terminal domain of RNA polymerase II. Genes, & Dev. 11: 2645-2657.
6. Drapkin, R., J.T. Reardon, A. Ansari, J.-C. Huang, L. Zawel, K. Ahn, A. Sancar, and D. Reinberg. 1994. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 368: 769-772.
7. Feinberg, M.B., D. Baltimore, and A.D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcription elongation. Proc. Natl. Acad. Sci. 88: 4045-4049.
8. Garcia-Martines, L., G. Mavankal, J. Neveu, W. Lane, D. Ivanov, and R. Gaynor. 1997. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850.
9. Garrett, K.P., T. Aso, J.N. Bradsher, S.I. Foundling, W.S. Lane, R.C. Conaway, and J.W. Conaway. 1995. Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc. Natl. Acad. Sci. 92: 7172-7176.
10. Gold, M.O., X. Yang, C.H. Herrmann, and A.P. Rice. 1998. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol. 72: 4448-4453.
11. Herrmann, C.H. and A.P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69: 1612-1620.
12. Jones, K.A. 1997. Taking a new TAK on Tat transactivation. Genes & Dev. 11: 2593-2599.
13. Jones, K.A. and B.M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Bochem. 63: 717-743.
14. Kao, S.Y., A.F. Calman, P.A. Luciw, and B.M. Peterlin. 1987. Antitermination of transcription within the long terminal repeat of HIV by the tat gene product. Nature 330: 489-493.
15. Kato, H., H. Sumimoto, P. Pognonec, C.H. Chen, C.A. Rosen, and R.G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factor. Genes & Dev. 6: 655-666.
16. Keen, N., M. Churcher, and J. Karn. 1997. Transfer of Tat and release of Tat RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16: 5260-5271.
17. Laspra, M.F., A.P. Rice, and M.B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stablizes elongation. Cell 59: 283-292.
18. Li, X.-Y. and M.R. Green. 1996a. Transcription elongation and Cancer. Curr. Biol. 6: 943-944.
19. _. 1996b. Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes & Dev. 10: 517-527.
20. Lillie, J.W. and M.R. Green. 1989. Transcriptional activation by the adenovirus E1a protein. Nature 338: 39-44.
21. Lin, Y.-S., M.F. Carey, M. Ptashne, and M.R. Green. 1988. GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell 54: 659-664.
22. Mancebo, H., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HTV Tat transcriptional activation in vivo and in vitro. Genes & Dev. 11: 2633-2644.
23. Marciniak, R.A. and P.A. Sharp. 1991. HIV-1 Tat protein promotes formation of more processive elongation complexes. EMBO J. 10: 4189-4196.
24. Marciniak, R.A., B.J. Calnan, A.D. Frankel, and P.A. Sharp. 1990. HIV-1 Tat protein trans-activates transcription in vitro. Cell 63: 791-802.
25. Parada, C. and R. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered hy Tat-induced phosphorylation of its carboxyl-terminal domain. Nature 384: 375-378.
26. Reine, D., J.W. Conaway, and R.C. Conaway. 1996. The RNA polymerase II general elongation factors. Trends Biochem. Sci. 21: 351-355.
27. Shilatifard, A., W.S. Lane, K.W. Jackson, R.C. Conaway, and J.W. Conaway. 1996. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271: 1873-1876.
28. Southgate, C.D. and M.R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes & Dev. 5: 2496-2507.
29. Sun̄é, C., T. Hayashi, Y. Liu, W.S. Lane, R.A. Young, and M.A. Garcia-Blanco. 1997. CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 17: 6029-6039.
30. Wei, P., M.E. Garber, S.-M. Fang, W.H. Fischer, and K.A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to Tar-RNA. Cell 92: 451-462.
31. Wu-Baer, F., W.S. Lane, and R.B. Gaynor. 1998. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277: 179-197.
32. Zhou, Q. and P.A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14: 321-328.
33. _. 1996. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274: 605-610.
34. Zhou, Q., D. Chen, E. Pierstorff, and K. Lou. 1998. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17: 3681-3691.
35. Zhu, Y., T. Peery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. Mathews, and D. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes & Dev. 11: 2622-2632.